MAI-001 is under clinical development by Nanjing Minova Pharmaceutical Technology and currently in Phase I for Depression.
Introducing Meteor™ chips on the IsoSpark™ platform: Advancing handsfree quantitative proteomics
We are pleased to introduce Meteor™ chips on the IsoSpark™ platform.